What is the CDTX stock price prediction for next 2 weeks?

According to our price prediction algorithm,Cidara Therapeutics, Inc. (CDTX) price will be around $225.40 in the next 2 weeks. This means it will increase by 1.816017707109943 from the last closing price. This prediction may vary from other time period filters for CDTX stock.

What can be the highest Possible price of CDTX stock in next 2 weeks?

Our forecast algorithm expects that in 2 weeks, CDTX can achieve the highest price of $246.17 which is 11.199077117283988 higher than last closing price. This prediction may vary from other time period filters for CDTX stock.

What can be the lowest Possible price of CDTX stock in next 2 weeks?

As per the forecast and algorithmic analysis, CDTX stock price can be as low as $204.77 which is -7.501238901924719 lower than the current price in the next 2 weeks. This prediction may vary from other time period filters for CDTX stock.

Will CDTX stock go high in the next 2 weeks?

Yes, our stock forecasting algorithm shows that CDTX stock will gain1.816017707109943 in the next 2 weeks. This prediction may vary from other time period filters for CDTX stock.

What is CDTX stock last closing price?

Last closing price of CDTX stock was $221.38.

What is CDTX stock price prediction?

CDTX stock price prediction means predicting the future closing prices of CDTX stock based on its past data. Our forecasting algorithm uses various machine learning and deep learning techniques to forecast the future behavior of CDTX stock in a certain time period.

How we predict CDTX stock future prices?

If you are searching for CDTX stock forecast, analysis or price prediction, then you might be wondering what Cidara Therapeutics, Inc. (CDTX) will do in the future. Our CDTX price predictions are based on various Machine Learning based algorithms with an aim to try and predict future price movements. This CDTX price prediction will likely answer most of your questions.

How frequent we update CDTX stock predictions?

We are updating the forecasts for the CDTX stock on daily basis.

Is using ML forecasting for CDTX stock a good way?

Yes. Stock Price Prediction is one of the most exciting applications of Machine Learning. By leveraging data from the past, it is possible to use forecasting models to make accurate predictions about future stock prices. This can be incredibly beneficial for investors and traders, as it gives them the ability to make more informed decisions about when to buy and sell. Investing in the stock market can be a risky endeavor, but leveraging Machine Learning can make it a bit less daunting and more profitable.

Is the Prediction for CDTX stock same for all the time periods?

No, the prediction for CDTX stock is not same for all time periods. The forecasts may vary depending on the differences in the time period.

Cidara Therapeutics, Inc. Stock Forecast and Stock Price Prediction

Stock Forecast Chart

Stock Price Prediction Summary

Closed Price$221.380%Since 2 Weeks

Predicted Price$225.401.82%For 2 Weeks

Upper Predicted Price$246.1711.2%For 2 Weeks

Lower Predicted Price$204.77-7.5%For 2 Weeks

Forecast Score Based on 2 Weeks

Based on our forecast, the price of CDTX will rise by +1.82% over the next 2 Weeks and hit $225.40 by Tuesday, January 20, 2026. In that time frame, CDTX's share price is expected to range between $204.77 and $246.17.

BearishAverageBullish

Date	Predicted Lower	Predicted	Predicted Upper
Jan 20, 2026	209.66	229.68	249.91
Jan 19, 2026	207.91	229.59	249.90
Jan 16, 2026	207.95	229.58	250.06
Jan 15, 2026	182.88	203.65	226.18
Jan 14, 2026	206.87	228.85	249.15
Jan 13, 2026	207.91	227.95	249.33
Jan 12, 2026	207.04	227.86	249.02
Jan 9, 2026	204.44	227.85	250.17
Jan 8, 2026	180.16	201.92	223.89
Jan 7, 2026	206.31	227.12	248.79

CDTX shares remained flat 0 in Thursday, January 8, 2026's trading session, starting and closing at a previous close of $221.38 to move at $221.38. The stock demonstrated notable intraday movement (see CDTX's key stats for a full breakdown), fluctuating between $221.38 and $221.38, a 0 trading range. While recent weeks have seen some volatility, CDTX has managed to secure a +0.24% gain over the past 2 weeks. The neutral price movement was accompanied by increased trading volume, with approximately 2.65M shares changing hands, 1.32M more than the previous session. This amounted to $586.84M in total market activity.

Will CDTX Continue Its Upward Trend?

According to analyst ratings and projections for CDTX, Cidara Therapeutics, Inc. shares are anticipated to increase by +11.42%, potentially reaching $249.91 per share by January 20, 2026. Short-term technical indicators currently suggest a neutral sentiment for CDTX. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 18 positive trading days within the past 30 sessions. Based on the CDTX stock forecast, now is a good time to buy CDTX stock because its current trading price is -3.61% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on CDTX covering social and institutional perspectives.

CDTX Technical Momentum: Overbought, Oversold, or Neutral?

An analysis of Relative Strength Index (RSI) indicators provides insight into CDTX's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 82.60% to 84.21%) indicate the stock is in a strong bullish momentum phase. The 50-day RSI, at 78.41%, indicates significant medium-term strength. Additionally, the 100-day RSI, at 75.20%, indicates a bearish outlook for the long term. Insights into CDTX's shareholder base show how institutional investors are positioning themselves during these momentum shifts

Cidara Therapeutics Short-Term Forecasts

CDTX Forecast For Next 5 Days

Our algorithm anticipates Cidara Therapeutics (CDTX) stock could hit $237.52 by Jan 23, 2026. This represents a +7.29% rise from today's price, following a +0.44% change over the past five days.

CDTX Forecast For Next 30 Days

Based on analysis of market trends, the outlook for Cidara Therapeutics, Inc. (CDTX) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $217.04, which would mean a -1.96% decrease from the current price of $221.38. Projections for this period range from a high of $277.73 to a low of $158.44.

CDTX Forecast For Next 90 Days

Our proprietary market analysis suggests predictions for Cidara Therapeutics's price over the next three months point to a drop. CDTX stock is expected to peak at $112.57 on May 12, 2026 before potentially dipping to $61.89 on Jun 16, 2026. On average, CDTX is likely to trade around $85.01 in the coming 90 days.

Cidara Therapeutics Stock Forecast 2025

Based on our predictive models, Cidara Therapeutics (CDTX) is expected to trade between $47.79 and $126.30 throughout 2026. This would result in an average price of $86.32, potentially offering investors a -61.01% return from current levels.

Cidara Therapeutics, Inc. Monthly Forecast 2026–2027

January 2026

According to our latest forecast models, Cidara Therapeutics, Inc. (CDTX) is positioned to show a strong performance in January 2026. The price is predicted to move between $47.79 and $84.09, settling at an average of $67.04. This could translate to a -69.72% loss.

February 2026

Based on current market signals, Cidara Therapeutics, Inc. is projected to trend february 2026. We forecast a trading range from $50.46 to $91.09, with a likely average price of $70.48. Investors could expect a potential return of -68.16%.

March 2026

Our predictive algorithms indicate Cidara Therapeutics, Inc. stock may see a shift in March 2026. The expected range spans $58.73–$93.35, with an average target of $75.91. This represents a cautious outlook and a possible loss of -65.71%.

April 2026

Analyzing established trends, Cidara Therapeutics, Inc. looks set to move in April 2026. Projections place the stock between $60.54 and $111.82, averaging around $86.21. This suggests a -61.06% loss from current levels.

May 2026

Market indicators suggest Cidara Therapeutics, Inc. could experience notable changes during May 2026. Prices could fluctuate within $76.99 to $112.57, with a midpoint forecast of $94.11. The stock might deliver a -57.49% loss.

June 2026

Forecasting for June 2026, models estimate that Cidara Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $61.89 and $107.67, averaging $80.42. This signals a cautious trajectory with potential returns around -63.67%.

July 2026

According to our latest forecast models, Cidara Therapeutics, Inc. (CDTX) is positioned to show a strong performance in July 2026. The price is predicted to move between $63.27 and $102.39, settling at an average of $81.46. This could translate to a -63.20% loss.

August 2026

Based on current market signals, Cidara Therapeutics, Inc. is projected to trend august 2026. We forecast a trading range from $70.58 to $102.77, with a likely average price of $86.58. Investors could expect a potential return of -60.89%.

September 2026

Our predictive algorithms indicate Cidara Therapeutics, Inc. stock may see a shift in September 2026. The expected range spans $68.64–$120.85, with an average target of $98.04. This represents a cautious outlook and a possible loss of -55.71%.

October 2026

Analyzing established trends, Cidara Therapeutics, Inc. looks set to move in October 2026. Projections place the stock between $87.09 and $126.30, averaging around $104.63. This suggests a -52.74% loss from current levels.

November 2026

Market indicators suggest Cidara Therapeutics, Inc. could experience notable changes during November 2026. Prices could fluctuate within $71.80 to $114.13, with a midpoint forecast of $89.54. The stock might deliver a -59.55% loss.

December 2026

Forecasting for December 2026, models estimate that Cidara Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $72.87 and $110.88, averaging $92.51. This signals a cautious trajectory with potential returns around -58.21%.

January 2027

According to our latest forecast models, Cidara Therapeutics, Inc. (CDTX) is positioned to show a strong performance in January 2027. The price is predicted to move between $81.94 and $112.15, settling at an average of $95.98. This could translate to a -56.64% loss.

CDTX's history of dividends and stock splits also plays a role in long-term investor confidence.